A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician?s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-b